Lin B - Search Results

1

Metformin inhibits the proliferation of A549/CDDP cells by activating p38 mitogen-activated protein kinase.

Wang Y, Lin B, Wu J, Zhang H, Wu B. Wang Y, et al. Among authors: lin b. Oncol Lett. 2014 Sep;8(3):1269-1274. doi: 10.3892/ol.2014.2270. Epub 2014 Jun 19. Oncol Lett. 2014. PMID: 25120704 Free PMC article.

2

Galangin inhibits proliferation of HepG2 cells by activating AMPK via increasing the AMP/TAN ratio in a LKB1-independent manner.

Zhang H, Li N, Wu J, Su L, Chen X, Lin B, Luo H. Zhang H, et al. Among authors: lin b. Eur J Pharmacol. 2013 Oct 15;718(1-3):235-44. doi: 10.1016/j.ejphar.2013.08.026. Epub 2013 Sep 9. Eur J Pharmacol. 2013. PMID: 24028940

3

Galangin inhibits proliferation of hepatocellular carcinoma cells by inducing endoplasmic reticulum stress.

Su L, Chen X, Wu J, Lin B, Zhang H, Lan L, Luo H. Su L, et al. Among authors: lin b. Food Chem Toxicol. 2013 Dec;62:810-6. doi: 10.1016/j.fct.2013.10.019. Epub 2013 Oct 22. Food Chem Toxicol. 2013. PMID: 24161691

4

Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway.

Wang Y, Wu J, Lin B, Li X, Zhang H, Ding H, Chen X, Lan L, Luo H. Wang Y, et al. Among authors: lin b. Toxicology. 2014 Dec 4;326:9-17. doi: 10.1016/j.tox.2014.09.010. Epub 2014 Sep 28. Toxicology. 2014. PMID: 25268046

5

Galangin suppresses hepatocellular carcinoma cell proliferation by reversing the Warburg effect.

Wang Y, Lin B, Li H, Lan L, Yu H, Wu S, Wu J, Zhang H. Wang Y, et al. Among authors: lin b. Biomed Pharmacother. 2017 Nov;95:1295-1300. doi: 10.1016/j.biopha.2017.09.056. Epub 2017 Oct 6. Biomed Pharmacother. 2017. PMID: 28938520

6

Inhibition of bleomycin-induced pulmonary fibrosis in mice by the novel peptide EZY-1 purified from Eucheuma.

Yu H , Zhang Z , Huang H , Wang Y , Lin B , Wu S , Ma J , Chen B , He Z , Wu J , Zhao Z , Zhang H . Yu H , et al. Among authors: lin b. Food Funct. 2019 Jun 19;10(6):3198-3208. doi: 10.1039/c9fo00308h. Food Funct. 2019. PMID: 31165849

7

Anti-Androgen Receptor Therapies in Prostate Cancer: A Brief Update and Perspective.

Huang J, Lin B, Li B. Huang J, et al. Among authors: lin b. Front Oncol. 2022 Mar 10;12:865350. doi: 10.3389/fonc.2022.865350. eCollection 2022. Front Oncol. 2022. PMID: 35372068 Free PMC article. Review.

8

TMEM158 expression is negatively regulated by AR signaling and associated with favorite survival outcomes in prostate cancers.

Huang J, Liu W, Zhang D, Lin B, Li B. Huang J, et al. Among authors: lin b. Front Oncol. 2022 Nov 1;12:1023455. doi: 10.3389/fonc.2022.1023455. eCollection 2022. Front Oncol. 2022. PMID: 36387246 Free PMC article.

9

Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer.

Chen X, Li Z, Liang M, Zhang Z, Zhu D, Lin B, Zhou R, Lu Y. Chen X, et al. Among authors: lin b. World J Surg Oncol. 2023 Jun 30;21(1):194. doi: 10.1186/s12957-023-03078-7. World J Surg Oncol. 2023. PMID: 37391802 Free PMC article.

10

AQ-4, a deuterium-containing molecule, acts as a microtubule-targeting agent for cancer treatment.

Lin BY, Liu WL, Huang H, Hu YG, Gong S, Meng YH, Yan J, Lu YZ, Chen HL. Lin BY, et al. Eur J Pharmacol. 2020 Jun 15;877:173093. doi: 10.1016/j.ejphar.2020.173093. Epub 2020 Mar 29. Eur J Pharmacol. 2020. PMID: 32234525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,908 results

Search Page

Filters